These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12415531)

  • 1. Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.
    Shytle RD; Silver AA; Sheehan KH; Sheehan DV; Sanberg PR
    Depress Anxiety; 2002; 16(3):89-92. PubMed ID: 12415531
    [No Abstract]   [Full Text] [Related]  

  • 2. Mecamylamine (Targacept).
    Singh A; Das DK; Kelley ME
    IDrugs; 2006 Mar; 9(3):205-17. PubMed ID: 16523387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD).
    Lindsley CW
    ACS Chem Neurosci; 2010 Aug; 1(8):530-1. PubMed ID: 22778844
    [No Abstract]   [Full Text] [Related]  

  • 4. Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders.
    Bacher I; Wu B; Shytle DR; George TP
    Expert Opin Pharmacother; 2009 Nov; 10(16):2709-21. PubMed ID: 19874251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?
    Taraschenko OD; Panchal V; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2005 Apr; 513(3):207-18. PubMed ID: 15862802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic acetylcholine receptors as targets for antidepressants.
    Shytle RD; Silver AA; Lukas RJ; Newman MB; Sheehan DV; Sanberg PR
    Mol Psychiatry; 2002; 7(6):525-35. PubMed ID: 12140772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine).
    Shytle RD; Silver AA; Sanberg PR
    Biol Psychiatry; 2000 Nov; 48(10):1028-31. PubMed ID: 11082479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
    Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
    Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Tourette's syndrome with mecamylamine.
    Sanberg PR; Shytle RD; Silver AA
    Lancet; 1998 Aug; 352(9129):705-6. PubMed ID: 9728992
    [No Abstract]   [Full Text] [Related]  

  • 10. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.
    Dwoskin LP; Crooks PA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):395-402. PubMed ID: 11454899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense inhibition of neuronal nicotinic receptors in the tobacco-feeding insect, Manduca sexta.
    Fickbohm D; Trimmer BA
    Arch Insect Biochem Physiol; 2003 Aug; 53(4):172-85. PubMed ID: 12886515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute ultra-low dose mecamylamine on cognition in adult attention-deficit/hyperactivity disorder (ADHD).
    Potter AS; Ryan KK; Newhouse PA
    Hum Psychopharmacol; 2009 Jun; 24(4):309-17. PubMed ID: 19475630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecamylamine increases cigarette smoking in psychiatric patients.
    Marx CE; McIntosh E; Wilson WH; McEvoy JP
    J Clin Psychopharmacol; 2000 Dec; 20(6):706-7. PubMed ID: 11106149
    [No Abstract]   [Full Text] [Related]  

  • 14. Mecamylamine in Tourette's syndrome: a two-year retrospective case study.
    Silver AA; Shytle RD; Sanberg PR
    J Child Adolesc Psychopharmacol; 2000; 10(2):59-68. PubMed ID: 10933116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mecamylamine on nicotine-induced conditioned hyperactivity and sensitization in differentially reared rats.
    Coolon RA; Cain ME
    Pharmacol Biochem Behav; 2009 Jul; 93(1):59-66. PubMed ID: 19379770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trapping blockage of muscle nicotinic cholinoreceptors by mecamilamine.
    Skorinkin AI; Ostroumov KB; Shaikhutdinova AR; Giniatullin RA
    Dokl Biol Sci; 2004; 399():464-6. PubMed ID: 15717609
    [No Abstract]   [Full Text] [Related]  

  • 17. Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers.
    Chi H; de Wit H
    Alcohol Clin Exp Res; 2003 May; 27(5):780-6. PubMed ID: 12766622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats.
    Rezvani AH; Bushnell PJ; Levin ED
    Psychopharmacology (Berl); 2002 Dec; 164(4):369-75. PubMed ID: 12457266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anger symptoms and "delinquent" behavior in Tourette syndrome with and without attention deficit hyperactivity disorder.
    Cavanna AE; Cavanna S; Monaco F
    Brain Dev; 2008 Apr; 30(4):308. PubMed ID: 17920219
    [No Abstract]   [Full Text] [Related]  

  • 20. Mecamylamine prevents neuronal apoptosis induced by glutamate and low potassium via differential anticholinergic-independent mechanisms.
    Fu H; Dou J; Li W; Luo J; Li KC; Lam CS; Lee NT; Li M; Han Y
    Neuropharmacology; 2008 Mar; 54(4):755-65. PubMed ID: 18222492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.